Skip to content
TrialScanner

NCT02316717

A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis

Phase 2CompletedIMRNLead

Registry record

Lead sponsor
Immuron Ltd.
Conditions
Non-alcoholic Steatohepatitis (NASH)
Primary completion
Oct 30, 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02316717 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02316717: A Phase ll Study of IMM-124E... | TrialScanner